ArticleCancer immunology, immunotherapy : CII2015

Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients.

Maria Grazia Cusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.